NCT00288717Unknown不适用
A Randomized, Comparative Study of the Effects of Candesartan and Telmisartan on the Home Blood Pressure, Glucose and Lipid Metabolism in the Hypertensive Patients With the Accumulation of Visceral Fat by the Central Registration System
适应症
相关药物
试验速览
- 阶段
- 不适用
- 入组人数
- 300
- 试验地点
- 2
- 主要终点
- Home blood pressure in the early morning
研究概览
简要总结
To investigate the effects of Candesartan and Telmisartan on the home blood pressure, glucose and lipid-metabolism in the hypertensive patients with the accumulation of visceral fat by the newly developed Tele-medicine system
详细描述
A randomized, comparative study of the effects of Candesartan and Telmisartan on the home blood pressure, glucose and lipid metabolism in the hypertensive patients with the accumulation of visceral fat by the central registration system
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Single
入排标准
- 年龄范围
- 20 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Circumference at waist: male ≧85 cm, female ≧90 cm
- •Hypertensive patient with untreated hypertension, and casual blood pressure of systole ≧140 mmHg, or diastole ≧90 mmHg
- •Hypertensive patient with hypertension under treatment, and casual blood pressure of systole ≧130 mmHg, or diastole ≧85 mmHg
排除标准
- •Significant hypertensive patient with diastolic blood pressure ≧120 mmHg
- •Malignant hypertensive patient
- •Patient with a contraindication to the study drugs (hypersensitivity, significant hepatic diseases, pregnant woman)
- •Patient with urinary protein (qualitative) ＋～＋＋
- •Patient with familial hyperlipidemia
- •Other patients judged as ineligible for the study
结局指标
主要结局
Home blood pressure in the early morning
次要结局
- Casual blood pressure
- Body fat percentage
- Body weight
- Height
- BMI
- Blood potassium
- Total cholesterol
- HDL cholesterol
- LDL cholesterol
- Triglyceride
- Blood glucose
- IRI
- HbAlc*
- HOMA-IR
- Urinary trace albumin
- Creatinine
- Home blood pressure at bedtime
- M/E ratio
研究者
研究点 (2)
Loading locations...
相似试验
已完成
4 期
Effectiveness of MICARDIS® (Telmisartan) on Blood Pressure Control and Quality of Live in Patients With Essential HypertensionHypertensionNCT02242370Boehringer Ingelheim3,045
已完成
3 期
Parallel-Group Comparison of Olmesartan (OLM), Amlodipine (AML) and Hydrochlorothiazid (HCTZ) in HypertensionEssential HypertensionNCT00923091Daiichi Sankyo2,689
已完成
不适用
Evaluation of the Effect of Telmisartan (Micardis® 80 mg/ MicardisPlus® 80/12.5 mg) on Blood Pressure and Cardiovascular Risk Factor Index in High Risk Hypertensive PatientsCardiovascular DiseasesHypertensionNCT00904371Boehringer Ingelheim211
已完成
3 期
Antihypertensive Efficacy and Safety of Candesartan/HCT 32/25 mg in Comparison With Individual Components and PlaceboHypertensionNCT00434967AstraZeneca2,207
已完成
3 期
BIBR 277 Capsule in Patients With Essential HypertensionHypertensionNCT02177448Boehringer Ingelheim225